Livzon Pharmaceutical Group Inc (000513) — Cash Flow-to-Debt Ratio
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥853.59 Million could theoretically repay 0% of its total liabilities (CN¥9.17 Billion) in one year. See Livzon Pharmaceutical Group Inc (000513) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Livzon Pharmaceutical Group Inc Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Livzon Pharmaceutical Group Inc across 27 annual periods. Also explore Livzon Pharmaceutical Group Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Livzon Pharmaceutical Group Inc (1998–2024)
Year-by-year debt coverage analysis for Livzon Pharmaceutical Group Inc. For market capitalisation and broader financial context, see Livzon Pharmaceutical Group Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -5.5% |
| 2023 | 0.33x | CN¥3.39 Billion | CN¥10.28 Billion | ▲ +18.3% |
| 2022 | 0.28x | CN¥2.77 Billion | CN¥9.93 Billion | ▲ +18.3% |
| 2021 | 0.24x | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -24.1% |
| 2020 | 0.31x | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +0.3% |
| 2019 | 0.31x | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +39.1% |
| 2018 | 0.22x | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -21.0% |
| 2017 | 0.28x | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -24.5% |
| 2016 | 0.37x | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +31.6% |
| 2015 | 0.28x | CN¥927.79 Million | CN¥3.27 Billion | ▲ +27.4% |
| 2014 | 0.22x | CN¥717.39 Million | CN¥3.22 Billion | ▲ +50.0% |
| 2013 | 0.15x | CN¥439.99 Million | CN¥2.96 Billion | ▼ -38.6% |
| 2012 | 0.24x | CN¥593.96 Million | CN¥2.45 Billion | ▼ -45.6% |
| 2011 | 0.45x | CN¥708.20 Million | CN¥1.59 Billion | ▼ -28.1% |
| 2010 | 0.62x | CN¥633.30 Million | CN¥1.02 Billion | ▲ +12.5% |
| 2009 | 0.55x | CN¥494.88 Million | CN¥898.92 Million | ▲ +73.7% |
| 2008 | 0.32x | CN¥345.18 Million | CN¥1.09 Billion | ▲ +21.7% |
| 2007 | 0.26x | CN¥248.55 Million | CN¥954.80 Million | ▲ +24.1% |
| 2006 | 0.21x | CN¥226.46 Million | CN¥1.08 Billion | ▲ +20.5% |
| 2005 | 0.17x | CN¥161.07 Million | CN¥925.20 Million | ▼ -1.2% |
| 2004 | 0.18x | CN¥181.46 Million | CN¥1.03 Billion | ▼ -43.9% |
| 2003 | 0.31x | CN¥300.01 Million | CN¥954.70 Million | ▲ +6.9% |
| 2002 | 0.29x | CN¥213.65 Million | CN¥727.05 Million | ▲ +21.1% |
| 2001 | 0.24x | CN¥155.15 Million | CN¥639.37 Million | ▲ +266.2% |
| 2000 | 0.07x | CN¥38.52 Million | CN¥581.24 Million | ▼ -84.3% |
| 1999 | 0.42x | CN¥246.23 Million | CN¥583.95 Million | ▲ +1245.0% |
| 1998 | -0.04x | CN¥-18.21 Million | CN¥494.51 Million | — |